Long QT Syndrome: The Heart-Rhythm Gene That Can Cause Sudden Death in Healthy Young People

A hidden electrical fault in the heart that can be triggered by common medications — and is often only found after a tragedy.

Long QT syndrome is an inherited disturbance in the heart's electrical recovery cycle. It can cause fainting, seizures, or sudden cardiac death — sometimes in young, athletic, apparently perfectly healthy people. It's also treatable once identified, which is what makes finding it so important.

Every heartbeat is an electrical event: the heart's cells fire, then "reset" to be ready for the next beat. On an ECG, that reset shows up as the QT interval. In Long QT syndrome (LQTS), the reset takes too long, leaving the heart electrically vulnerable during a critical window. If a chaotic rhythm called torsades de pointes is triggered in that window, the heart can stop pumping effectively — causing collapse or, in the worst case, sudden death.

The main genes

LQTS is usually caused by variants in genes coding for the ion channels that move potassium and sodium in and out of heart cells — the very machinery of the electrical reset.

• KCNQ1 (LQT1) — a potassium channel; events are often triggered by exercise, especially swimming.
• KCNH2 (LQT2) — another potassium channel; events are classically triggered by sudden loud noises (like an alarm clock) and emotional stress.
• SCN5A (LQT3) — a sodium channel; events more often occur during rest or sleep.

Those trigger patterns aren't just trivia — they shape lifestyle advice once a subtype is known.

Why it's so often missed until it's too late

Many people with LQTS have no symptoms until a catastrophic event. When a young athlete collapses and dies during a game, an inherited channelopathy like LQTS is one of the culprits investigators look for. And because it's inherited (usually autosomal dominant), a single case in a family often means several relatives carry the same variant, unaware.

The medication trap

A huge number of common medications can prolong the QT interval — certain antibiotics, antihistamines, antipsychotics, antidepressants, anti-nausea drugs and more. In someone with underlying LQTS, an ordinary prescription can push them into dangerous territory (this is "acquired" or drug-induced QT prolongation layered on genetic risk). Knowing you carry an LQTS variant lets you and your doctors avoid QT-prolonging drugs — a concrete, life-protecting use of genetic information.

How genome data fits in

A whole genome sequence can flag variants in KCNQ1, KCNH2, SCN5A and other channelopathy genes. But cardiac channelopathy genetics is an area where interpretation is everything: many variants are of uncertain significance, and a genetic finding should always be paired with an ECG and a cardiology assessment. Conversely, a normal genetic test doesn't fully exclude LQTS, since not all cases have an identifiable variant. Genetics and the ECG work together.

The good news: it's manageable

Once identified, LQTS is one of the more manageable inherited cardiac conditions. Depending on subtype and risk, options include beta-blocker medication, avoiding QT-prolonging drugs, avoiding specific triggers (like competitive swimming for some LQT1 patients), correcting electrolyte imbalances, and in higher-risk cases an implantable defibrillator. The gap between "undiagnosed and vulnerable" and "diagnosed and protected" is enormous — which is the whole argument for knowing.

This article is for general educational purposes only and is not medical advice. Genetic results should be interpreted with a qualified healthcare provider or genetic counselor. Do not start, stop, or change any medication or treatment based on this article.